Abstract: Twenty-four mutacin-producing Streptococcus mutans strains were screened for their propensity to produce class II one-peptide bacteriocin using a deferred antagonism assay. Streptococcus salivarius and 3 mutants defective in their mannose phosphotransferase systems (mannose-PTS) were used as sensitive strains to identify which mannose-PTS could act as the docking site for class II one-peptide bacteriocin activity. We observed that only 2 strains of S. mutans, T9 and 3B, potentially produce class II one-peptide bacteriocin, namely mutacins I-T9 and R-3B, but with no preference for any mannose-PTS complex as a target.
Bacteriocins are ribosomally synthesized antimicrobial peptides produced by prokaryotes (Jack et al. 1995) . Mutacins are bacteriocins produced by Streptococcus mutans, a human indigenous bacterial species evolving in the mouth (Hamada and Ooshima 1975) . Bacteriocins can be classified into 3 classes: class I, including lantibiotics containing posttranslationally modified amino acids; class II, regrouping nonlantibiotics, containing only nonmodified amino acids; and class III, containing large bacteriocins (Jack et al. 1995; Drider et al. 2006) . Class II bacteriocins are subdivided into several subclasses: subclass IIa, the pediocin-like bacteriocins; subclass IIb, the two-peptide bacteriocins; subclass IId, the leaderless bacteriocins; and subclass IIc, all other class II bacteriocins (Drider et al. 2006) . Our research group classified 86 mutacin-producing strains into 24 groups (designated A to X) according to their immunity towards their own mutacin and their activity spectra against bacterial pathogens (Morency et al. 1995) . Mutacins appeared to be difficult to produce in liquid and purify (Nicolas et al. 2004 (Nicolas et al. , 2006 , and an emphasis on the diversity of antimicrobial substances produced by S. mutans has been recently highlighted by bioinformatic analysis (Nicolas et al. 2007a ). The primary function of the mannose phosphotransferase system (mannose-PTS) is to concomitantly take up and phosphorylate sugars in bacteria (Postma et al. 1993) . Studies have shown that the mannose-PTS might serve as a receptor for activity of class IIa and class IIc one-peptide bacteriocins (Dalet et al. 2001; Ramnath et al. 2004; Diep et al. 2007) , but this has not been shown for mutacins. Since we previously identified that S. mutans 59.1 produces a pediocin-like mutacin (Nicolas et al. 2007b ), we tested the activity of our mutacinproducing strains against a Streptococcus salivarius strain (ATCC 25975) and 3 isogenic mutants altered in 2 mannose-PTS encoding operons to identify which of our strains could produce class II one-peptide mutacins targeting the mannose-PTS of S. salivarius. The QC 205, QC 206, and QC 207 mutants are, respectively, deprived of the man operon that comprises the gene coding for the IIAB L Man (Lortie et al. 2000) , the man and mhf operons, and the mhf operon that comprises the gene for the IIAB H Man (Gauthier et al. 1990; Pelletier et al. 1998; Lortie et al. 2000; Bart et al. 2007) .
Based on previous reports (Dalet et al. 2001; Diep et al. 2007; Ramnath et al. 2004) , the class II one-peptide-like mutacin-producing S. mutans strains should not be active against the defective mannose-PTS S. salivarius mutants. These mutants being completely altered in only one or both mannose-PTS, we could also pinpoint the specific binding target of these kinds of mutacins.
We used the deferred antagonism assay (Morency et al. 2001) to test the activity of our mutacin-producing S. mutans strains against the S. salivarius strains. Briefly, mutacin-producing strains were grown on tryptic soy agar with yeast extract for 48 h at 37 8C and covered with a layer of soft (0.75%) agar (5 mL) containing 500 mL of the indicator strain (overnight culture diluted to OD 590 nm of 0.1 for Micrococcus luteus or 0.2 for S. salivarius strains in tryptic soy broth yeast extract (TSBYE) to obtain confluent growth). The following sensitive strains were used: parental strain S. salivarius ATCC 25975 and S. salivarius mannose-PTS mutant strains QC 205 (man -), QC 206 (man -and mhf -), QC 207 (mhf -). Streptococcus salivarius mannose-PTS mutant strains were selected by the addition of kanamycin (Sigma-Aldrich, St. Louis, Mo.) in the TSBYE and in soft agar (1% (v/v) of a solution of 500 mg/mL). Micrococcus luteus ATCC 272 was used as a positive control of bacteriocin inhibition. The pediocin PA-1 producer strain Pediococcus acidilactici UL5 (Daba et al. 1994 ) was used as a positive control for pediocin production in the deferred antagonism assay. The tests were done in triplicate, and the results are reported as the mean radius of 3 inhibition zones measured from the edge of the colony of the producing strain to the margin of the inhibition zone (Morency et al. Pediococcus acidilactici UL-5 1 0 0 0 0 Note: The activity is expressed as the mean of the radius of 3 inhibition zones (in mm). The mode of standard deviation found on these measures was 0.6 mm. *, p 0.2: radius of inhibition zone significantly different from that of S. salivarius ATCC 25975, as found by a Kruskal-Wallis test.
2001). A Kruskal-Wallis test was performed to identify significant differences between inhibition zones observed for S. salivarius strains (p value 0.2). Activity of pure mutacin F-59.1 (Nicolas et al. 2007b ) was tested against the indicator strains using the critical dilution method (Nicolas et al. 2004) . Results showed that the pediocin producer strain P. acidilactici UL-5 is unfortunately not active against S. salivarius ATCC 25975, meaning that the presence of functional mannose-PTS is not sufficient for pediocin activity against S. salivarius ATCC 25975 or that the docking molecule is not accessible for pediocin PA-1 activity. Pediocinlike bacteriocins are rarely reported to be active against strains of streptococci ( Diep et al. 2006 , Eijsink et al. 1998 . We also observed that all mutacin-producing S. mutans are active against S. salivarius and their mannose-PTS mutants along with M. luteus (Table 1) . Some S. mutans strains (Q, 59.1, T8, 87.1, and 11A) are more active against M. luteus than S. salivarius, while S. mutans strains (T9, 25175, 3B, Ny257, F, NG003) are more active against S. salivarius. Streptococcus mutans 59.1, producing the pediocin-like mutacin F-59.1 (Nicolas et al. 2007a (Nicolas et al. , 2007b , inhibits the growth of S. salivarius and its mannose-PTS mutants. A similar level of activity of purified mutacin F-59.1 was observed against the different strains of S. salivarius, suggesting that this pediocin-like mutacin does not specifically target the mannose-PTS of S. salivarius. The mutacin lantibiotic producing strains (Ny266, 29B, T8, 123.1) showed the same activity against wild-type and mannose-PTS mutants of S. salivarius, confirming that lantibiotics do not target the mannose-PTS complex but rather the lipid II (Hasper et al. 2006) . Hitherto, we cannot exclude the possible inaccessibility of the docking molecule mannose-PTS for mutacin lantibiotics. From the 24 mutacin-producing S. mutans strains, only T9 and 3B showed significant differences in their activity against the wild-type and mannose-PTS mutants of S. salivarius (Table 1) . Activity was stronger against the wild type of S. salivarius, suggesting that the mannose-PTS could enhance the activity of mutacins I-T9 and R-3B by playing a receptor function for these 2 mutacins (Diep et al. 2007; Kjos et al. 2009 ). However, mutacins I-T9 and R-3B do not seem to have a preferential mannose-PTS target, being equally less active against the 3 mutants tested. The deletions created in the QC 205, QC 206, and QC 207 mutants looped out complete operons and are not restricted to active site residues of the mannose-PTS. Thus, the differences observed for the binding of mutacins could not be related to interactions with the unaltered portions of the mannose-PTS components or lower levels of production.
The resistance of S. salivarius to pediocin could be explained in part by bioinformatic analysis. A phylogenetic tree was constructed to position the mannose-PTS of S. salivarius among members of mannose-PTS known to serve as receptors for class II one-peptide bacteriocin as demonstrated by experimental analysis conducted by Kjos et al. (2009) . Amino acids sequences of mannose-PTS IIC proteins of bacterial species were collected from the Entrez Gene Database (http://www.ncbi.nlm.nih.gov/sites/entrez) and were used to construct the tree. Phylogenetic analysis was performed using the Web service Phylogeny.fr (http:// www.phylogeny.fr; Dereeper et al. 2008) . Sequences were aligned using MUSCLE version 3.7 (Edgar 2004 ) in default mode. The phylogenetic tree was constructed with the maximum likelihood algorithm implemented in PhyML version 3.0 (Guindon and Gascuel 2003) and was visualized using TreeDyn (Chevenet et al. 2006) . Results show that the mannose-PTS complex IIC of S. salivarius is related to the mannose-PTS group with low-sensitivity receptor potency for class II one-peptide bacteriocins, as found by Kjos et al. (2009) (Fig. 1) . Furthermore, using the LALiGN program from the ExPASy proteomic server (Huang and Miller 1991) (S. salivarius ATCC 25975 mannose-PTS IIC (ACN23006.1 or AAD46486.1)) and those from other species (Listeria monocytogenes EDG-e (NP 463630.1) and Enterococcus faecalis V583 (NP 813832.1)) were used as query sequences before running the program in default mode), we observed that the complex IIC from the mannose-PTS of S. salivarius shows only partial identity (around 30%) with other mannose-PTS IIC in the vicinity of the regions identified by Kjos et al. (2009) that could be involved in the specificity of the receptor potency for class IIa bacteriocins (Fig. 2) . We preliminarily identified 2 S. mutans strains (T9 and 3B) that potentially produced class II onepeptide mutacin targeting the mannose-PTS of S. salivarius but with no apparent difference for any mannose-PTS (man or mhf). We are purifying these 2 mutacins to completely characterize them. 
